So, what does this shift mean for stakeholders in the medical device industry – especially for regulatory affairs professionals, manufacturers, and auditors? This article dives deep into how digitalizing technical documentation is reshaping the landscape of medical device regulatory submissions.

Technical documentation is the backbone of any medical device approval process. It includes comprehensive data on the device’s design, manufacturing, performance, safety, risk management, clinical evaluations, labeling, and more. Regulatory bodies like the FDA (U.S.), MHRA (UK), and notified bodies under the EU MDR require this documentation to ensure that devices are safe, effective, and compliant with regulatory standards.

But traditional methods of handling this documentation pose serious challenges. Paper-based systems are prone to human error, difficult to update, and time-consuming to audit. Even electronic systems without integration or proper digital workflows can lead to inconsistencies and non-compliance.

Role of Digitalization/AI in Regulatory Affairs

Digitalization in this context refers to converting paper-based or analog processes into a digital format that is structured, searchable, and integrated across systems. It’s not just about scanning documents into PDFs; it involves the use of software platforms, databases, cloud storage, and AI tools to automate, validate, and manage technical documents more efficiently.

For instance, a digital document management system (DMS) allows companies to centralize their documentation, maintain version control, automate updates, and ensure traceability – all of which are essential for regulatory audits and inspections. When done right, digitalization enhances transparency, reduces human error, and shortens time to market.

Benefits of Digitalizing Technical Documentation

Digitalizing regulatory submissions brings several tangible benefits to medical device companies:

1. Improved Efficiency and Speed

Digitally managed documents can be accessed, edited, and shared across teams in real time. This leads to faster reviews, quicker approvals, and reduced time-to-market for new devices.

2. Enhanced Accuracy and Consistency

With automation tools, data entry errors and redundant information are minimized. Changes made in one section of the document can automatically reflect across all linked documents, maintaining consistency.

3. Easier Collaboration

Digital platforms enable multiple stakeholders – engineers, regulatory specialists, QA teams, and management – to collaborate seamlessly, no matter where they are located.

4. Better Compliance and Audit Readiness

Digital systems offer audit trails, version history, and access logs, making it easier to prove compliance during audits or inspections.

5. Cost Reduction

Although the initial setup of digital tools may require investment, over time they significantly reduce the costs associated with printing, storing, and managing paper documents.

Challenges in Adopting Automation

Despite its benefits, digitalization is not without hurdles:

1. Resistance to Change

Many organizations are deeply entrenched in traditional processes. Convincing teams to adopt new digital tools can be met with skepticism and resistance.

2. Initial Investment

The cost of acquiring and implementing digital platforms can be high, especially for small and medium-sized enterprises (SMEs). However, the ROI justifies the expense in the long run.

3. Data Security and Privacy

Storing sensitive regulatory data digitally necessitates robust cybersecurity measures to prevent data breaches, especially when dealing with patient-related information or proprietary designs.

4. Training and Skill Gaps

Employees need to be trained on new systems, which takes time and resources. Bridging this skill gap is essential for successful digital transformation.

Key Components of Digital Technical Documentation

For digitalization to be effective, certain core components must be incorporated into the system:

1. Document Management Systems (DMS)

A robust DMS is the foundation of digital technical documentation. It offers secure storage, version control, approval workflows, and access management.

2. Electronic Signatures and Audit Trails

Regulatory bodies accept electronic signatures under standards such as FDA’s 21 CFR Part 11. These features ensure accountability and compliance, allowing traceability of who approved or modified documents and when.

3. Integrated Quality Management Systems (QMS)

Digital QMS platforms integrate with DMS, linking quality processes like CAPA (Corrective and Preventive Actions), complaints, and risk assessments directly with the corresponding technical documentation.

4. Cloud-Based Access

Remote access to technical documentation is increasingly important, especially with the global nature of teams and audits. Cloud solutions ensure real-time access while maintaining security and compliance.

5. Metadata and Searchability

Digitized documents with metadata tagging improve navigation and retrieval. Instead of sifting through paper files, users can perform quick searches to find relevant content instantly.

Regulatory Expectations for Digitalization

While digitalization is primarily driven by internal efficiency, it also aligns with the evolving expectations of regulatory authorities. Agencies are increasingly recognizing the legitimacy of digital documents and workflows, provided they meet strict criteria:

• Traceability – Clear records of who accessed or altered a document and when.
• Validation – Systems must be validated to prove they function correctly and consistently.
• Security – Protection against unauthorized access, data corruption, or loss.
• Retention – Documents must be preserved in a readable format for a defined period.

Although regulatory agencies vary in their digital readiness, the trend is moving toward greater acceptance of digital documentation, making early adoption a competitive advantage.

Best Practices for Implementing Digital Documentation Systems

Transitioning to a fully digital documentation system requires strategic planning. Here are some best practices:

1. Assess Current Workflows

Map out your existing document lifecycle – from creation to approval – and identify pain points or redundancies that digital tools can address.

2. Choose the Right Platform

Not all digital tools are created equal. Select platforms that are compliant with relevant standards, scalable, and user-friendly.

3. Pilot the System

Start with a pilot project involving a limited number of documents and users. This helps identify issues and fine-tune workflows before full-scale rollout.

4. Train Your Team

Conduct comprehensive training sessions to ensure that everyone understands how to use the new system and follows best practices.

5. Maintain Continuous Improvement

Regularly evaluate the effectiveness of your digital documentation system and make improvements based on feedback and audit findings.

Case Studies: Success Stories in Digital Transformation

Case Study 1: Medium-Sized Manufacturer in Europe

A mid-sized medical device company in Germany transitioned from paper-based documentation to a cloud-based DMS. The result? A 40% reduction in submission preparation time and a 60% decrease in audit non-conformities.

Case Study 2: U.S.-Based Startup

A U.S.-based startup leveraged digital tools from the beginning, integrating its QMS and DMS on a single platform. This streamlined their FDA 510(k) and ISO 13485 submission processes, helping them go to market 6 months ahead of schedule.

These examples illustrate that organizations of all sizes can benefit from embracing digitalization – so long as the transition is thoughtfully executed.

Conclusion

Digitalization of technical documentation in medical device regulatory submissions is no longer a futuristic concept – it’s a present-day necessity. It enhances efficiency, compliance, and collaboration while paving the way for faster innovation and safer patient outcomes. By moving away from paper-based processes and embracing integrated digital systems, medical device companies can not only meet today’s regulatory expectations but also future-proof their operations.

Digital transformation is not just about technology – it’s about mindset. Regulatory affairs teams that embrace change and invest in robust digital systems will lead the next wave of healthcare innovation.

If you are a medical device manufacturer or regulatory professional looking to streamline your documentation processes and accelerate approvals, DDi can help in digitalization to future-proof your compliance strategy.

In general, an eIFU is defined as a non-paper version of the instructions for use. Currently, the definition of an eIFU is not the same in each market.

In the EU, according to the Commission Implementing Regulation EU 2021/2226, which laid down rules for the application of Regulation (EU) 2017/745 of the European Parliament and of the Council in regards to electronic instructions for use of medical devices, instructions for use in electronic format means “instructions for use displayed in electronic form by the device, contained in portable electronic storage media supplied by the manufacturer together with the device, or made available through software or website.”

European eLabeling regulation 2021/2226 

The Medical Device Regulation (MDR) introduces a comprehensive framework that integrates multiple electronic instructions for use (eIFU) requirements, further supplemented by Implementing Regulation (EU) 2021/2226, the successor to Commission Regulation (EU) 207/2012.

Requirements for the use of electronic instructions for use as per regulation (EU) 2021/2226 

According to Implementing Regulation (EU) 2021/2226, instructions for use may be provided electronically (eIFU) instead of on paper if certain conditions are met:

1. The device should fall into a specific class, as mentioned below:
   • Implantable and active implantable medical devices and their accessories
   • Fixed installed medical devices and their accessories
   • Medical devices and their accessories fitted with a built-in system visually displaying the instructions for use (e.g., ultrasound equipment)
2. The devices and accessories are intended for exclusive use by professional users
3. The use by other  people is not reasonably foreseeable
4. For software, manufacturers may provide eIFUs within the software itself.

Manufacturers of Medical devices that provide instructions for use in electronic form to users instead of in paper form shall undertake a documented risk assessment which shall cover at least the following elements:

• Knowledge and experience of the intended users in particular regarding the use of the device and user needs;
• Characteristics of the environment in which the device will be used;
• knowledge and experience of the intended user of the hardware and software needed to display the instructions for use in electronic form;
• Access of the user to the reasonably foreseeable electronic resources needed at the time of use;
• Performance of safeguards to ensure that the electronic data and content are protected from tampering;
• Safety and backup mechanisms in the event of a hardware or software fault, particularly if the instructions for use in electronic form are integrated within the device;
• Foreseeable medical emergency situations requiring the provision of information in paper form;
• Impact caused by the temporary unavailability of the specific website, of the internet in general, or of their access in the healthcare institution, as well as the safety measures available to cope with such a situation;
• Evaluation of the period within which the instructions for use shall be provided in paper form at the user’s request;
• Assessment of the website’s compatibility with displaying the electronic instructions for use with different devices that could be used to display those instructions;
• Management of different versions of the instructions for use, where applicable

Factors to consider when switching to an electronic IFU for your medical device

1. Risk assessment

eIFU must maintain or improve the level of safety compared to providing a paper IFU. Your risk assessment needs to examine this carefully. For instance, if your device is sometimes used by nurses or doctors in rural locations where the internet may be spotty, what additional risks might that present? You will need to update your risk management procedures and forms to account for this.

2. Product packaging

The location of the eIFU must be indicated on the packaging for each unit or, in the case of fixed devices, on the device itself. For obvious reasons, you cannot simply place PDFs of your IFU on your website and assume professional users will know to look there. The Regulation makes it clear that your packaging must clearly specify that the IFU is in electronic format and where it can be found. Except for software and devices with screens, the IFU may reside on a website, and its location may be communicated via a website URL or QR code. If you choose the latter, make sure you document the pros and cons of using QR codes in your risk assessment and update your labeling work instructions as needed.

3. Validation

Ensure the user’s access is precise by having accurate product data in real-time and a solution for delivering the information in the user’s preferred language.

4. Method of delivery

If you make software as a medical device (SaMD) or a device with a larger display screen, the method of delivery may be the device itself. For all other devices, device manufacturers will most likely deliver IFUs via their website. This fulfills a key requirement that the information be provided in a universally available format (thumb drives and DVDs are no longer universal). The preamble of the new eIFU regulation says, “To ensure unconditional access to the instructions for use in electronic form and to facilitate the communication of updates, those instructions should be available on the website of the manufacturer in an official language of the Union determined by the Member State in which the device is made available to the user or patient.” This does not mean you cannot deliver your eIFU on a private YouTube channel, for example.

5. Paper version

There are professionals out there who prefer paper-based instructions, or (it is true) might not have reliable internet access. It is EU law to have paper IFUs, with the exception of some devices. If a paper-based option is required, you are obligated to provide a paper version within seven calendar days of the request at no cost. In cases where video or animation is not used, the eIFU may simply be a printed copy of the PDF you maintain online. Make sure to update your labeling SOP with this requirement.

6. Online security

Making your IFU available online is easy. Ensuring that it does not accidentally get removed or replaced is not possible. You will need to put procedures in place to ensure that your sales and marketing departments do not change the URL, delete old versions, or otherwise change the document. You should really think of the master IFU web page(s) as controlled documents, not just the IFU itself.

7. Archival procedures

For devices without a defined expiration date, your IFU needs to be maintained for 15 years after the last device has been placed on the market. For devices with an expiration date, this changes to 10 years. You also need to have a system for indicating when changes have been made (change control) and a way to inform each user if the change was made for safety reasons. Finally, all historical versions of the IFU must be made available on the website.

8. Privacy policy

Europe has one of the strictest online privacy laws in the world, known simply as the GDPR (General Data Protection Regulation 2016/679). If you will be asking the user to provide their name and/or email, or if your website has cookies enabled (most do), you will need to make sure you are following the GDPR.

Advantages of eIFU over paper-based instructions:

• Enhanced accessibility: considering the high internet coverage, electronic instructions can be accessed digitally and consulted anywhere, providing easier search and navigation and greater flexibility.
• Real-time updates: eIFU allows for immediate updates and revisions, ensuring that users always have the latest information about the product they are using. This is crucial for patient safety and optimal device utilization.
• User-friendly interfaces: Electronic formats enable the incorporation of multimedia elements, such as videos and interactive features, enhancing the clarity and effectiveness of instructions.
• Increased efficiency in MDR implementation: electronic formats facilitate the inclusion of multiple languages and therefore contribute to reducing the risk of shortages of medical devices and improving the overall availability of these devices, especially in a multilingual context like the European Union.
• Cost efficiency: Over time, the implementation of eIFU can lead to cost savings for both manufacturers and healthcare institutions, as the need for printing, distribution, storage, and waste management of paper IFU is significantly reduced.
• Environmentally sustainable: The transition to eIFU aligns with broader efforts to reduce paper usage, contributing to environmental sustainability and supporting the EU Green Deal.

Going forward, manufacturers seeking to sell their products in the European market must comply with the EU eIFU regulations. Adhering to these regulations will provide greater flexibility and reduce the risk of product recalls related to IFUs. If you are in the process of updating your device labels and preparing eIFUs, feel free to contact DDi for expert assistance.

Digital solutions are Different for small/middle

The National Center for the Middle Market (NCMM) actively monitors the state of technology implementation and digital change at mid-size companies a focus that began in 2019 even before the pandemic hit. We define the middle market as companies with revenues between $10 million and $1 billion annually, a wide range, for sure, but representative of the middle-third of the U.S. private sector in terms of GDP and employment. While the scale of technology investment can vary greatly across middle-market companies of different sizes as well as industries, there are still common issues prevalent for mid-market leaders across the spectrum as they consider making a move toward an increasingly digital future.

Managing Change

Strategies for midsize companies and beyond.

Perhaps most notably, resources capital, people, time are always an issue. Regulatory resources are typically more constrained in mid-size companies than in a larger enterprise where digital initiatives are often strategically managed by a dedicated department or team. On the other end of the spectrum, small businesses aren’t typically in a position to even need such platforms, so the resource challenge is unique to the middle market. Another challenge is the reality that, in most cases, the “trendy” digital systems and tools are either (1) too expensive, (2) not scaled appropriately for current needs, and/or (3) require a great deal of support to implement (and possibly maintain).

4 Keys for Planning Successful Change

So how should middle-market leadership teams think about navigating technological changes given the very real limitations they face? Our research suggests that whether your business is just starting to think about becoming more digital, or is already somewhere down the path, there are some important considerations to keep in mind to help ensure a better fit and return on investment:

Platform: Are you investing in something entirely new? Or are you bolting on new capabilities to a system already in place? Either way, allocating more budget to strategic development, and regulatory analytics over daily management of the regulatory function will generate greater long-term return.

Budget: With limited resources for investment, and possible financial barriers, are sufficient budgets being allocated in the right ways? Depending on the system(s) involved, return on investment can take longer to achieve. Consider what tradeoffs might be required based on the most pressing priorities security, efficiency, productivity, analytics, and so forth.

Processes: Are the investments being considered compatible with customers and suppliers? A secondary benefit of technology implementation is streamlining connectivity and creating end-to-end visibility from regulatory to the supply chain, for instance. Picking a system based solely on cost or provider might not be the right approach if your upstream and downstream functions are doing something different. Think about what might need to change by process-mapping key functions.

Risk Management: With new technology comes the potential for new exposures. Have you evaluated the key risks and developed the proper security measures to protect your most vital digital assets? Using a trusted partner can be very helpful in identifying blind spots or new threats that might not have existed in the old set-up.

Make Sure It All Ties Back to Strategy

These four considerations and their implications will invariably differ across organizations. But regardless of the nuances for any individual middle-market company, regulatory leadership should also take a step back to consider some broader questions as the company navigates its own digital journey.

These strategic questions include:

To what extent do we aspire to be among the leaders in our industry in creating business value from digital technologies?

Does our company have a digital vision that is clear and comprehensive; widely understood internally and externally by employees, customers, and partners; and used to guide strategic decisions?

Does our company have a strategy to use digital technologies to achieve competitive advantage, increase revenue, and use capital more effectively?

Careful consideration and alignment across the organization on these underlying premises can lead to remarkable results. Companies with self-described strategic digital processes grew at notably faster rates than their peers.

The Promise of Digital Solutions Makes Change Management a Must

Make no mistake navigating technological change and implementation can be daunting, even for large enterprise companies. However, with the right mindset, strategic approach, and willingness to leverage outside resources as needed, regulatory function in middle-market companies can lean into change with eyes wide open, primed to extract most if not all of the benefits of digital solutions to drive greater efficiency, collaboration, and growth in an increasingly competitive world.

Visit our regulatory digitization Page now to learn more and elevate your business to new heights.